Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H25N3O2 |
| Molecular Weight | 375.4635 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CC2=CC3=C(ON=C3CCC4CCN(CC5=CC=CC=C5)CC4)C=C2N1
InChI
InChIKey=MTCMTKNMZCPKLX-UHFFFAOYSA-N
InChI=1S/C23H25N3O2/c27-23-13-18-12-19-20(25-28-22(19)14-21(18)24-23)7-6-16-8-10-26(11-9-16)15-17-4-2-1-3-5-17/h1-5,12,14,16H,6-11,13,15H2,(H,24,27)
| Molecular Formula | C23H25N3O2 |
| Molecular Weight | 375.4635 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Icopezil (previously known as CP-118,954) was developed as a selective acetylcholinesterase inhibitor for the treatment of cognitive disorders. Phase II trials of icopezil were underway in Japan and in the USA for the treatment of patients with Alzheimer's disease. However, Pfizer has discontinued these studies.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and evaluation of radioiodine-labelled CP-118,954 for the in-vivo imaging of acetylcholinesterase. | 2007-07 |
|
| Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase. | 2005-02 |
|
| Synthesis and evaluation of 5,7-dihydro-3-[2-[1-(4-[18F]-fluorobenzyl)-4-piperidinyl]ethyl]-6H-pyrrolo[3,2-f]-1,2-benzisoxazol-6-one for in vivo mapping of acetylcholinesterase. | 2004-06 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:29:57 GMT 2025
by
admin
on
Mon Mar 31 19:29:57 GMT 2025
|
| Record UNII |
ERZ60E6B7C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47792
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C99558
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
145508-78-7
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
172972
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
100000083673
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
DTXSID70932622
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
7492
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL359570
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
SUB08108MIG
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY | |||
|
ERZ60E6B7C
Created by
admin on Mon Mar 31 19:29:57 GMT 2025 , Edited by admin on Mon Mar 31 19:29:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
DERIVATIVE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
